Title:
NOVEL HUMAN GUT-DERIVED LACTIC ACID BACTERIA HAVING IMMUNE REGULATORY FUNCTION, AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2017/131402
Kind Code:
A1
Abstract:
According to the present invention, a specific Lactobacillus sp. strain, a specific Bifidobacterium sp. strain, a specific Streptococcus sp. strain or a specific Collinsella sp. strain is isolated from human feces, and thus has high safety, and has various physiological activities such as an immune regulatory effect, an immune enhancement effect, an anti-allergic effect, an anti-inflammatory effect, a colitis alleviation effect, an arthritis alleviation effect, an anti-obesity effect, an anti-stress effect, an anti-anxiety effect, an anti-depression effect or an anti-schizophrenia effect. According to the present invention, the specific Lactobacillus sp. strain, the specific Bifidobacterium sp. strain, the specific Streptococcus sp. strain or the specific Collinsella sp. strain can be used as a material for immune regulation, immune enhancement, inflammatory response inhibition, and stress alleviation, and can also be used as a functional food and pharmaceutical material useful for preventing, alleviating or treating allergic diseases, inflammatory diseases, colitis, arthritis, obesity, anxiety disorders, depression, schizophrenia or the like.
Inventors:
KIM DONG HYUN (KR)
HAN MYUNG JOO (KR)
HAN MYUNG JOO (KR)
Application Number:
PCT/KR2017/000792
Publication Date:
August 03, 2017
Filing Date:
January 24, 2017
Export Citation:
Assignee:
UNIV-INDUSTRY COOP GROUP OF KYUNG HEE UNIV (KR)
International Classes:
C12N1/20; A23L33/135; A61K35/744; A61K35/745; A61K35/747; C12R1/01; C12R1/225; C12R1/23; C12R1/25; C12R1/46
Domestic Patent References:
| WO2014132982A1 | 2014-09-04 |
Foreign References:
| KR20050057259A | 2005-06-16 | |||
| KR20090114279A | 2009-11-03 | |||
| US20110206650A1 | 2011-08-25 | |||
| US20110206649A1 | 2011-08-25 | |||
| KR20150098202A | 2015-08-27 |
Attorney, Agent or Firm:
KO, Young Kap (KR)
Download PDF: